This hypothesis is supported by several cross-sectional studies showing a higher proportion of mycobacteria-specific IFN+IL2−TNF+ or IFNg+IL2− CD4 T cells or lower IL2+ CD4 T cells in patients with active TB than in patients after successful treatment [24], [30]–[32]. The gene discussed is IFNA1; the disease is tuberculosis.